WallStSmart

Medline Inc. Class A Common Stock (MDLN)vsRetractable Technologies Inc (RVP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medline Inc. Class A Common Stock generates 74404% more annual revenue ($28.43B vs $38.16M). MDLN leads profitability with a 4.1% profit margin vs -22.9%. MDLN earns a higher WallStSmart Score of 52/100 (C-).

MDLN

Buy

52

out of 100

Grade: C-

Growth: 6.0Profit: 5.0Value: 8.3Quality: 7.8
Piotroski: 4/9

RVP

Hold

39

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDLNUndervalued (+32.7%)

Margin of Safety

+32.7%

Fair Value

$66.92

Current Price

$42.03

$24.89 discount

UndervaluedFair: $66.92Overvalued

Intrinsic value data unavailable for RVP.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDLN0 strengths · Avg: 0/10

No standout strengths identified

RVP2 strengths · Avg: 10.0/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
73.2%10/10

Revenue surging 73.2% year-over-year

Areas to Watch

MDLN4 concerns · Avg: 3.0/10
P/E RatioValuation
29.9x4/10

Moderate valuation

Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

Free Cash FlowQuality
$-113.00M2/10

Negative free cash flow — burning cash

RVP4 concerns · Avg: 2.3/10
Market CapQuality
$24.25M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-10.8%2/10

ROE of -10.8% — below average capital efficiency

EPS GrowthGrowth
-66.7%2/10

Earnings declined 66.7%

Free Cash FlowQuality
$-1.35M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : MDLN

Revenue growth of 14.8% demonstrates continued momentum.

Bull Case : RVP

The strongest argument for RVP centers on Price/Book, Revenue Growth. Revenue growth of 73.2% demonstrates continued momentum.

Bear Case : MDLN

The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.

Bear Case : RVP

The primary concerns for RVP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

MDLN profiles as a value stock while RVP is a hypergrowth play — different risk/reward profiles.

RVP is growing revenue faster at 73.2% — sustainability is the question.

RVP generates stronger free cash flow (-1M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MDLN scores higher overall (52/100 vs 39/100) and 14.8% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medline Inc. Class A Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Visit Website →

Retractable Technologies Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States, the rest of North and South America, and internationally. The company is headquartered in Little Elm, Texas.

Want to dig deeper into these stocks?